Search Results

There are 1989 results for: content related to: Yttrium 90 radioembolization: The horizon is changing for patients with intermediate and advanced hepatocellular carcinoma

  1. Towards new response criteria in neuroendocrine tumors: Which changes in MRI parameters are associated with longer progression-free survival after radioembolization of liver metastases?

    Journal of Magnetic Resonance Imaging

    Volume 41, Issue 2, February 2015, Pages: 361–368, Felix Ceelen, Daniel Theisen, Xabier García de Albéniz, Christoph J. Auernhammer, Alexander R. Haug, Melvin D'Anastasi, Philipp M. Paprottka, Carsten Rist, Maximilian F. Reiser and Wieland H. Sommer

    Version of Record online : 21 JAN 2014, DOI: 10.1002/jmri.24569

  2. You have free access to this content
    Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation

    Hepatology

    Volume 54, Issue 3, 2 September 2011, Pages: 868–878, Bruno Sangro, Livio Carpanese, Roberto Cianni, Rita Golfieri, Daniele Gasparini, Samer Ezziddin, Philipp M. Paprottka, Francesco Fiore, Mark Van Buskirk, Jose Ignacio Bilbao, Giuseppe Maria Ettorre, Rita Salvatori, Emanuela Giampalma, Onelio Geatti, Kai Wilhelm, Ralf Thorsten Hoffmann, Francesco Izzo, Mercedes Iñarrairaegui, Carlo Ludovico Maini, Carlo Urigo, Alberta Cappelli, Alessandro Vit, Hojjat Ahmadzadehfar, Tobias Franz Jakobs, Secondo Lastoria and on behalf of the European Network on Radioembolization with Yttrium-90 Resin Microspheres (ENRY)

    Version of Record online : 30 JUN 2011, DOI: 10.1002/hep.24451

  3. Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 620–626, Jens Ricke, Karsten Bulla, Frank Kolligs, Markus Peck-Radosavljevic, Peter Reimer, Bruno Sangro, Eckart Schott, Kerstin Schütte, Chris Verslype, Jerzy Walecki, Peter Malfertheiner and for the SORAMIC study group

    Version of Record online : 8 JUL 2014, DOI: 10.1111/liv.12622

  4. Effect of yttrium-90 radioembolization on outcomes in Asian patients with early to advanced stage hepatocellular carcinoma

    Hepatology Research

    Hyun Young Woo, Do Young Kim, Jeong Heo, Chang Won Kim, Suk Kim, Ki Tae Yoon, Won Lim, Young Mi Hong, Jong Yun Won, Sangheun Lee, Kwang Hyub Han and Mong Cho

    Version of Record online : 2 AUG 2016, DOI: 10.1111/hepr.12759

  5. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 11, November 2014, Pages: 1897–1904, Philip Chong-Hei Kwok, Kwong Chuen Leung, Moon Tong Cheung, Ting Wa Lam, Lok Tin Szeto, Sandas Qi-Hua Chou, Nam Hung Chia, Cheuk Man Tong, Pui Kei Yuen, Chun Hung Cheung and Chun Key Law

    Version of Record online : 13 NOV 2014, DOI: 10.1111/jgh.12621

  6. Survival and tolerability of liver radioembolization: a comparison of elderly and younger patients with metastatic colorectal cancer

    HPB

    Volume 16, Issue 12, December 2014, Pages: 1110–1116, Samer Tohme, Daniel Sukato, Gary W Nace, Albert Zajko, Nikhil Amesur, Philip Orons, Didier Chalhoub, James W Marsh, David A Geller and Allan Tsung

    Version of Record online : 14 AUG 2014, DOI: 10.1111/hpb.12307

  7. You have free access to this content
    Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: A review of the literature

    Journal of Medical Imaging and Radiation Oncology

    Volume 58, Issue 3, June 2014, Pages: 341–352, Lourens Bester, Baerbel Meteling, David Boshell, Terence C. Chua and David L. Morris

    Version of Record online : 3 MAR 2014, DOI: 10.1111/1754-9485.12163

  8. Locoregional therapies for metastatic colorectal carcinoma to the liver—An evidence-based review

    Journal of Surgical Oncology

    Volume 110, Issue 2, August 1, 2014, Pages: 182–196, Minzhi Xing, David A. Kooby, Bassel F. El-Rayes, Nima Kokabi, Juan C. Camacho and Hyun S. Kim

    Version of Record online : 24 APR 2014, DOI: 10.1002/jso.23619

  9. Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases

    British Journal of Surgery

    Volume 97, Issue 4, April 2010, Pages: 537–543, C. Q. Cao, T. D. Yan, L. Bester, W. Liauw and Professor D. L. Morris

    Version of Record online : 4 MAR 2010, DOI: 10.1002/bjs.6931

  10. Internal Radiation Therapy for Liver Tumors

    Malignant Liver Tumors: Current and Emerging Therapies, Third Edition

    Ahsun Riaz, Laura Kulik, Michael Abecassis, Riad Salem, Pages: 131–138, 2009

    Published Online : 9 DEC 2009, DOI: 10.1002/9781444317053.ch12

  11. You have free access to this content
    Radiologic–pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1185–1193, Ahsun Riaz, Laura Kulik, Robert J. Lewandowski, Robert K. Ryu, Georgia Giakoumis Spear, Mary F. Mulcahy, Michael Abecassis, Talia Baker, Vanessa Gates, Ritu Nayar, Frank H. Miller, Kent T. Sato, Reed A. Omary and Riad Salem

    Version of Record online : 19 NOV 2008, DOI: 10.1002/hep.22747

  12. Serious hepatic complications of selective internal radiation therapy with yttrium-90 microsphere radioembolization for unresectable liver tumors

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue 3, September 2014, Pages: 266–272, James C Kuo, Andrea Tazbirkova, Robert Allen, Suzanne Kosmider, Peter Gibbs and Desmond Yip

    Version of Record online : 19 AUG 2014, DOI: 10.1111/ajco.12229

  13. You have free access to this content
    Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

    Hepatology

    Volume 57, Issue 5, May 2013, Pages: 1826–1837, Vincenzo Mazzaferro, Carlo Sposito, Sherrie Bhoori, Raffaele Romito, Carlo Chiesa, Carlo Morosi, Marco Maccauro, Alfonso Marchianò, Marco Bongini, Rodolfo Lanocita, Enrico Civelli, Emilio Bombardieri, Tiziana Camerini and Carlo Spreafico

    Version of Record online : 22 MAR 2013, DOI: 10.1002/hep.26014

  14. Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 1036–1047, Annagiulia Gramenzi, Rita Golfieri, Cristina Mosconi, Alberta Cappelli, Alessandro Granito, Alessandro Cucchetti, Sara Marinelli, Cinzia Pettinato, Virginia Erroi, Silvia Fiumana, Luigi Bolondi, Mauro Bernardi, Franco Trevisani and on behalf ofBLOG (Bologna Liver Oncology Group)

    Version of Record online : 20 MAY 2014, DOI: 10.1111/liv.12574

  15. You have free access to this content
    Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis

    Cancer

    Volume 121, Issue 13, July 1, 2015, Pages: 2164–2174, Nima Kokabi, Juan C. Camacho, Minzhi Xing, Bassel F. El-Rayes, James R. Spivey, Stuart J. Knechtle and Hyun S. Kim

    Version of Record online : 6 APR 2015, DOI: 10.1002/cncr.29275

  16. Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement

    HPB

    Volume 12, Issue 5, June 2010, Pages: 313–320, Roderich E. Schwarz, Ghassan K. Abou-Alfa, Jeffrey F. Geschwind, Sunil Krishnan, Riad Salem and Alan P. Venook

    Version of Record online : 28 MAY 2010, DOI: 10.1111/j.1477-2574.2010.00183.x

  17. You have free access to this content
    Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: Biological lessons, current challenges, and clinical perspectives

    Hepatology

    Volume 58, Issue 6, December 2013, Pages: 2188–2197, Riad Salem, Vincenzo Mazzaferro and Bruno Sangro

    Version of Record online : 4 OCT 2013, DOI: 10.1002/hep.26382

  18. You have free access to this content
    Prognostic factors and prevention of radioembolization-induced liver disease

    Hepatology

    Volume 57, Issue 3, March 2013, Pages: 1078–1087, Belen Gil-Alzugaray, Ana Chopitea, Mercedes Iñarrairaegui, Jose I. Bilbao, Macarena Rodriguez-Fraile, Javier Rodriguez, Alberto Benito, Inés Dominguez, Delia D'Avola, Jose I. Herrero, Jorge Quiroga, Jesus Prieto and Bruno Sangro

    Version of Record online : 15 FEB 2013, DOI: 10.1002/hep.26191

  19. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery

    Journal of Surgical Oncology

    Volume 105, Issue 4, 15 March 2012, Pages: 342–350, Akshat Saxena, Terence C. Chua, Jing Zhao and David L. Morris

    Version of Record online : 17 OCT 2011, DOI: 10.1002/jso.22114

  20. Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI

    Journal of Magnetic Resonance Imaging

    Volume 42, Issue 3, September 2015, Pages: 818–827, Juliane Schelhorn, Jan Best, Marcus P. Reinboldt, Alexander Dechêne, Guido Gerken, Marcus Ruhlmann, Thomas C. Lauenstein, Gerald Antoch and Sonja Kinner

    Version of Record online : 17 DEC 2014, DOI: 10.1002/jmri.24827